Brazilian influencer regrets using Ozempic after surgeon told her she was not eligible for butt implant because muscles were 'atrophied'

A Brazilian doctor and influencer is ruing the day she took Ozempic to shed a couple of pounds off her already lean frame after learning that she could not get an butt implant.

Dayanne Bezerra broke down in tears on Monday after she visited a clinic and was told by the surgeon that she was not a candidate for the butt lift because the muscles had lost tone and strength.

'Guys, I just went to the doctor because I wanted to get implants in my butt, right, and get a reconstruction because I've lost a lot of weight,' she told her 4 million followers via Instagram Stories on Monday. 

'The doctor said that my butt atrophied. Can you believe it? And the doctor already knows me. He knows my body. He asked what was happening to me.

'I am so sad in the world that my butt atrophied. And he didn't even put in implants to fix it. He's not going to reconstruct it, he's not going to do anything. That's it for me.'

In a second video, Bezerra can be seen crying over her appearance.

'You guys, I am so sad, you have no idea. How can a person lose weight to look pretty, and look ugly?' she said as she paced the hallway of a local mall. 'I am ugly.'

Bezerra appeared to have gotten over her sorrows with a shopping trip with friends to Louis Vuitton.

She drew criticism in May 2023 when she was filmed at an airport injecting herself with Ozempic, the prescription medicine that treats type 2 diabetes.

The video went viral on social media, causing her to issue a public statement and clearing any confuses it may have generated.

'Guys, there's a page posting that I'm taking my Ozempic at the airport. Yes, guys, I took my Ozempic at the airport,' she said. 'My life is busy, I had forgotten mine at home and bought another one at the pharmacy, but I don't take Ozempic on my advice.

'I have a prescription from my nutritionist, where he prescribes Ozempic for weight loss. And so, as far as I know, the medicine is not prohibited for weight loss. It is used for other treatments.'

Semaglutide (sold as Ozempic and Wegovy) and tirzepatide (Mounjaro) have been hailed as a key breakthrough in the battle against obesity.

The pens, taken once a day, mimics a hormone called GLP-1 and tricks the brain and body into thinking it is full, curbing appetite. 

Trials show semaglutide, manufactured by Danish firm Novo Nordisk, helps users lose up to 33 pounds on average in around a year.

Side effects of the jabs including bloating, nausea and acid reflux have long been noted by the government's drugs watchdog National Institute for Health and Care Excellence (NICE). 

Increasing numbers of Ozempic users on social media have also complained of being left with gaunt facial features, sagging 'melted candle' skin, 'empty' breasts and hair loss – which are not thought to be a direct side effect of the medication but a consequence of dramatic slimming.

Some patients have bizarrely claimed that jabs of Ozempic has turned them to act 'out of character,' engaging in risky sex, compulsive gambling or even making rash major life decisions such as filing for divorce. 

They believe changes levels of the brain chemical dopamine, possibly linked to the jabs, may be behind the issue, contributing to the ever-growing list of downsides.

The researchers, from London, say patients should be warned about the potential of these bizarre reactions, known collectively as impulse-control disorder, before starting on the drugs.